US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

October 20, 2020

Catalyst Pharmaceuticals, Inc. v. Xavier Becerra, et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. January 23, 2023

    After Catalyst Case, FDA Won't Stop Approving Orphan Drugs

    The U.S. Food and Drug Administration has said a loss in litigation involving a treatment for a rare autoimmune disease won't stop it from approving new orphan drugs if they have usage instructions different from a previous orphan drug that treats the same condition.

7 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login